Page last updated: 2024-08-17

quinoxalines and Machado-Joseph Disease

quinoxalines has been researched along with Machado-Joseph Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, R; Greenstein, PE; Jahan, I; Miller, A; Perlman, SL; Sullivan, KL; Wecker, L; Zesiewicz, TA1
De Michele, G; Filla, A; Sacca, F1
Connolly, BS; Lang, AE; Marras, C; Prashanth, LK; Shah, BB1

Trials

1 trial(s) available for quinoxalines and Machado-Joseph Disease

ArticleYear
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.
    Neurology, 2012, Feb-21, Volume: 78, Issue:8

    Topics: Adult; Affect; Aged; Benzazepines; Double-Blind Method; Female; Gait; Humans; Machado-Joseph Disease; Male; Middle Aged; Motor Activity; Nicotinic Agonists; Quinoxalines; Treatment Outcome; Varenicline

2012

Other Studies

2 other study(ies) available for quinoxalines and Machado-Joseph Disease

ArticleYear
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.
    Neurology, 2012, May-08, Volume: 78, Issue:19

    Topics: Benzazepines; Female; Humans; Machado-Joseph Disease; Male; Nicotinic Agonists; Quinoxalines

2012
A randomized trial of varenicline (chantix) for the treatment of spinocerebellar ataxia type 3.
    Neurology, 2012, Nov-27, Volume: 79, Issue:22

    Topics: Benzazepines; Female; Humans; Machado-Joseph Disease; Male; Nicotinic Agonists; Quinoxalines

2012